Jinwu Financial News | Spai Health (00314) announced that in 2023, the company achieved a loss attributable to parent company owners of 256 million yuan (RMB, same below), a sharp decrease over the previous year; the basic loss per share was 0.4 yuan, compared to 12.19 yuan in the same period last year.
During the period, the company achieved revenue of 4.712 billion yuan, an increase of 14.4% year on year; gross profit of 415 million yuan, an increase of 22.9% year on year.
By business, the company's specialty pharmacy business revenue was 4.188 billion yuan, up 14.4% year on year; doctor research assistance business revenue was 362 million yuan, up 13.3% year on year; and health insurance service business was 162 million yuan, up 17.4% year on year.